ESC Premium Access

Clinical questions: management of patients with atrial fibrillation

Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session type: Abstract Sessions
Date: 30 August 2021
Time: 07:15 - 08:00


5 presentations in this session

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study

Speaker: Doctor T. Chao (Taipei, TW)

Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes

Speaker: Assistant Professor Y. Kim (Gwangju, KR)

Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)

Speaker: Doctor M. Anjum (Baerum, NO)

Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

Speaker: Professor L. Fauchier (Tours, FR)

Low incidence of major complications after the first six hours post-atrial fibrillation ablation - same-day discharge safe and feasible in most patients

Speaker: Doctor A. Paul Nordin (Stockholm, SE)

5 speakers from this session

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
3 presentations
0 follower

Assistant Professor Yoo Ri Kim

Chonnam National University Hospital, Gwangju (Korea (Republic of))
1 presentation
0 follower

Doctor Mariam Anjum

Baerum Hospital, Baerum (Norway)
0 follower

Professor Laurent Fauchier

Tours Regional University Hospital, Hospital Trousseau, Tours (France)
12 presentations
1 follower

Doctor Astrid Paul Nordin

Karolinska Institutet Huddinge, Stockholm (Sweden)
0 follower

This platform is supported by

logo Novo Nordisk